Aller au contenu principal
Mantapex
Will the FDA approve intismeran autogene (V940/mRNA-4157)?
intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanomaScience
Kalshi Actif 5 marchés·95¢ Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Jul 1, 2028?·$0 Volume total·-- Liquidité·-- OI
5mo·Apr 8, 2027

Suivez vos positions sur les marchés de prédiction

Connectez votre compte Kalshi pour suivre vos contrats, votre P&L et vos règlements.

Écart large
Aucune donnée de graphique disponible

Marchés

5
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Jul 2028
$0 vol
95% --
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Jan 2028
$0 vol
88% ▲0.0%
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Oct 2027
$0 vol
71% ▼7.0%
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Jul 2027
$0 vol
15% ▲0.0%
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Apr 2027
$0 vol
4% --
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Jul 2028
Aucune donnée de carnet d'ordres disponible

If the FDA approves intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma for marketing before Apr 1, 2027, then the market resolves to Yes.

Séries

KXFDAAPPROVE
Voir la série complète

Suivez vos paris sur Kalshi — et tout le reste

Créez un portefeuille gratuit à partir de vos positions Kalshi, P&L et cotes en direct. Ajoutez ensuite des portefeuilles crypto, exchanges, DeFi et plus — tout en un seul endroit.

Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% gratuit· Lecture seule· Chiffré